A Multi-National Randomized Phase-III GCIG Intergroup-Study Comparing 1st-line Chemotherapy With Gemcitabine/Paclitaxel/Carboplatin vs Paclitaxel/Carboplatin In Previously Untreated Patients With Epithelial Ovarian Cancer FIGO Stages I-IV
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Gemcitabine (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results (n=4578) of validation of prognostic value of KELIM regarding PFS and OS in phase 3 trial (AGO-OVAR 9, AGO-OVAR 7, ICON 7) datasets presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 09 Oct 2010 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 09 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.